SAMHD1 restricts HIV-1 infection in resting CD4 + T cells

Nature Medicine

Volumn 18, Issue 11, 2012, Pages 1682-1687

  Baldauf, Hanna Mari ^a,b   Pan, Xiaoyu ^a   Erikson, Elina ^a,b   Schmidt, Sarah ^a   Daddacha, Waaqo ^c   Burggraf, Manja ^d   Schenkova, Kristina ^a   Ambiel, Ina ^a,b   Wabnitz, Guido ^a   Gramberg, Thomas ^e   Panitz, Sylvia ^d   Flory, Egbert ^d   Landau, Nathaniel R ^f   Sertel, Serkan ^a   Rutsch, Frank ^g   Lasitschka, Felix ^a   Kim, Baek ^c,h   König, Renate ^d,i   Fackler, Oliver T ^a   Keppler, Oliver T ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d PAUL EHRLICH INSTITUT   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h Kyung Hee University   (South Korea)

ⁱ BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEASOME; PROTEIN X; SAMHD1 PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

AICARDI GOUTIERES SYNDROME; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; IN VIVO STUDY; LYMPHOID ORGAN; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRION; VIRUS REPLICATION;

AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HIV-2; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MONOMERIC GTP-BINDING PROTEINS; NERVOUS SYSTEM MALFORMATIONS; REVERSE TRANSCRIPTION; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 84869170593     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2964     Document Type: Article

References (47)

1. Doitsh, G. et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143, 789-801 (2010
2. Ganesh, L. et al. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426, 853-857 (2003 (Pubitemid 38056872)
3. Korin, Y.D. & Zack, J.A. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161-3168 (1998 (Pubitemid 28175559)
4. Pierson, T.C. et al. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76, 8518-8531 (2002 (Pubitemid 34864046)
5. Stevenson, M., Stanwick, T.L., Dempsey, M.P. & Lamonica, C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560 (1990
6. Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990
7. Dai, J. et al. Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells. J. Virol. 83, 4528-4537 (2009
8. Plesa, G. et al. Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. J. Virol. 81, 13938-13942 (2007 (Pubitemid 350247888)
9. Yoder, A. et al. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 134, 782-792 (2008
10. Swingler, S. et al. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424, 213-219 (2003 (Pubitemid 36858691)
11. Bergamaschi, A. et al. The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J. Virol. 83, 4854-4860 (2009
12. Berger, G., Goujon, C., Darlix, J.L. & Cimarelli, A. SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors. Gene Ther. 16, 159-163 (2009
13. Goujon, C. et al. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J. Virol. 82, 12335-12345 (2008
14. Pertel, T., Reinhard, C. & Luban, J. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology 8, 49 (2011
15. Sharova, N. et al. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog. 4, e1000057 (2008
16. Srivastava, S. et al. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 4, e1000059 (2008
17. Berger, A. et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 7, e1002425 (2011
18. Eckstein, D.A. et al. HIV-1 actively replicates in naive CD4+ T cells residing within human lymphoid tissues. Immunity 15, 671-682 (2001 (Pubitemid 33016451)
19. Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661 (2011
20. Laguette, N. et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657 (2011
21. Goldstone, D.C. et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480, 379-382 (2011
22. Lahouassa, H. et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13, 223-228 (2012
23. Powell, R.D., Holland, P.J., Hollis, T. & Perrino, F.W. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J. Biol. Chem. 286, 43596-43600 (2011
24. Diamond, T.L. et al. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J. Biol. Chem. 279, 51545-51553 (2004 (Pubitemid 40017904)
25. Wabnitz, G.H. et al. Sustained LFA-1 cluster formation in the immune synapse requires the combined activities of L-plastin and calmodulin. Eur. J. Immunol. 40, 2437-2449 (2010
26. Santoni de Sio, F.R. & Trono, D. APOBEC3G-depleted resting CD4+ T cells remain refractory to HIV1 infection. Plos One 4, e6571 (2009
27. Thiele, H. et al. Cerebral arterial stenoses and stroke: Novel features of Aicardi-Goutieres syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. Hum. Mutat. 31, E1836-E1850 (2010
28. Lim, E.S. et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11, 194-204 (2012
29. Laguette, N. et al. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11, 205-217 (2012
30. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217 (2010
31. Manel, N. & Littman, D.R. Hiding in plain sight: How HIV evades innate immune responses. Cell 147, 271-274 (2011
32. Keppler, O.T. et al. Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 75, 8063-8073 (2001 (Pubitemid 32743678)
33. Haller, C. et al. The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J. Biol. Chem. 281, 19618-19630 (2006 (Pubitemid 44035465)
34. Goffinet, C. et al. HIV-1 antagonism of CD317 is species specific and involves Vpumediated proteasomal degradation of the restriction factor. Cell Host Microbe 5, 285-297 (2009
35. Goffinet, C., Allespach, I. & Keppler, O.T. HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proc. Natl. Acad. Sci. USA 104, 1015-1020 (2007 (Pubitemid 46154728)
36. Sunseri, N., O'Brien, M., Bhardwaj, N. & Landau, N.R. Human immunodeficiency virus type 1 modified to package simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J. Virol. 85, 6263-6274 (2011
37. Gramberg, T., Sunseri, N. & Landau, N.R. Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J. Virol. 84, 1387-1396 (2010
38. Berger, A. et al. Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. J. Biol. Chem. 285, 12248-12254 (2010
39. Keppler, O.T., Tibroni, N., Venzke, S., Rauch, S. & Fackler, O.T. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1. J. Leukoc. Biol. 79, 616-627 (2006 (Pubitemid 44831238)
40. Geuenich, S. et al. Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density. Retrovirology 5, 27 (2008
41. Tervo, H.M., Goffinet, C. & Keppler, O.T. Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration. Retrovirology 5, 58 (2008
42. Keppler, O.T. et al. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 79, 1655-1665 (2005 (Pubitemid 40459112)
43. Ruggieri, A. et al. Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec. Retrovirology 6, 17 (2009
44. Erikson, E. et al. In vivo expression profile of the antiviral restriction factor and tumortargeting antigen CD317/BST-2/HM1.24/tetherin in humans. Proc. Natl. Acad. Sci. USA 108, 13688-13693 (2011
45. Swiggard, W.J. et al. Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J. Virol. 79, 14179-14188 (2005 (Pubitemid 41552716)
46. Goffinet, C., Schmidt, S., Kern, C., Oberbremer, L. & Keppler, O.T. Endogenous CD317/ Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J. Virol. 84, 11374-11384 (2010
47. Verhoeyen, E. et al. IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101, 2167-2174 (2003 (Pubitemid 36302054)